COMBINATION OF IL13RALPHA2 CAR T-CELL THERAPY WITH PD-1 IMMUNE CHECKPOINT BLOCKADE FOR TREATMENT OF GLIOBLASTOMA
$236,627FY2017Department of the ArmyDOD
Northwestern University, Evanston IL
Investigators
View source on USAspending →COMBINATION OF IL13RALPHA2 CAR T-CELL THERAPY WITH PD-1 IMMUNE CHECKPOINT BLOCKADE FOR TREATMENT OF GLIOBLASTOMA · GrantIndex